[Clinical study of clindamycin-2-palmitate treatment in pediatric infections (author's transl)].
D000038:Abscess / Q000188:drug therapy; D002648:Child; D002981:Clindamycin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D004653:Empyema / Q000188:drug therapy; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D009625:Noma / Q000188:drug therapy; D010169:Palmitic Acids / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011014:Pneumonia / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects; D014069:Tonsillitis / Q000188:drug therapy
D010169:Palmitic Acids; D002981:Clindamycin